Publication:
Recent Advances in Allergen-Specific Immunotherapy as Treatment for Allergic Asthma: A Practical Overview.

dc.contributor.authorTabar, Ana I
dc.contributor.authorDelgado, Julio
dc.contributor.authorGonzález-Mancebo, Eloina
dc.contributor.authorArroabarren, Esozia
dc.contributor.authorSoto Retes, Lorena
dc.contributor.authorDomínguez-Ortega, Javier
dc.contributor.authorSpanish Allergy and Clinical Immunology Scientific Society (SEAIC)
dc.date.accessioned2023-02-09T10:43:20Z
dc.date.available2023-02-09T10:43:20Z
dc.date.issued2021-02-25
dc.description.abstractThe Global Initiative for Asthma Report updated in 2019 stated that potential benefits of allergen immunotherapy (AIT), compared to pharmacological and avoidance options, must be weighed against the risk of adverse effects and the inconvenience and cost of the prolonged course of therapy in asthma. Thus, with the aim of clarifying some aspects with regard to the possible use of AIT in allergic asthma treatment armamentarium, a group of expert allergists from the Spanish Allergy and Clinical Immunology Scientific Society (SEAIC), particularly from the Immunotherapy and Asthma Interest Groups developed a frequently asked questions in clinical practice. This document updates relevant topics on the use of AIT in asthma and could facilitate physician clinical decisions and improve health outcomes for individual patients.
dc.identifier.doi10.1159/000513811
dc.identifier.essn1423-0097
dc.identifier.pmid33631755
dc.identifier.unpaywallURLhttps://www.karger.com/Article/Pdf/513811
dc.identifier.urihttp://hdl.handle.net/10668/17234
dc.issue.number6
dc.journal.titleInternational archives of allergy and immunology
dc.journal.titleabbreviationInt Arch Allergy Immunol
dc.language.isoen
dc.organizationHospital Universitario Virgen Macarena
dc.organizationHospital Universitario Virgen Macarena
dc.page.number496-514
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.rights.accessRightsopen access
dc.subjectAllergy
dc.subjectAsthma
dc.subjectClinical practice
dc.subjectImmunotherapy
dc.subject.meshAge Factors
dc.subject.meshAllergens
dc.subject.meshAntibody Specificity
dc.subject.meshAsthma
dc.subject.meshBiomarkers
dc.subject.meshClinical Decision-Making
dc.subject.meshClinical Trials as Topic
dc.subject.meshCost-Benefit Analysis
dc.subject.meshDesensitization, Immunologic
dc.subject.meshDisease Management
dc.subject.meshHumans
dc.subject.meshImmunoglobulin E
dc.subject.meshPrognosis
dc.subject.meshSeverity of Illness Index
dc.subject.meshTreatment Outcome
dc.titleRecent Advances in Allergen-Specific Immunotherapy as Treatment for Allergic Asthma: A Practical Overview.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number182
dspace.entity.typePublication

Files